Real-Time Quantitative PCR Assays for Detection andMonitoring of Pathogenic Human Viruses in ImmunosuppressedPediatricPatients

ABSTRACT A panel of 23 real-time PCR assays based on TaqMan technology has been developed for the detection and monitoring of 16 different viruses and virus families including human polyomaviruses BK virus and JC virus, human herpesviruses 6, 7, and 8, human adenoviruses, herpes simplex viruses 1 and 2, varicella-zoster virus, cytomegalovirus, Epstein-Barr virus, parvovirus B19, influenza A and B viruses, parainfluenza viruses 1 to 3, enteroviruses, and respiratory syncytial virus. The test systems presented have a broad dynamic range and display high sensitivity, reproducibility, and specificity. Moreover, the assays allow precise quantification of viral load in a variety of clinical specimens. The ability to use uniform PCR conditions for all assays permits simultaneous processing and detection of many different viruses, thus economizing the diagnostic work. Our observations based on more than 50,000 assays reveal the potential of the real-time PCR tests to facilitate early diagnosis of infection and to monitor the kinetics of viral proliferation and the response to treatment. We demonstrate that, in immunosuppressed patients with invasive virus infections, surveillance by the assays described may permit detection of increasing viral load several days to weeks prior to the onset of clinical symptoms. In virus infections for which specific treatment is available, the quantitative PCR assays presented provide reliable diagnostic tools for timely initiation of appropriate therapy and for rapid assessment of the efficacy of antiviral treatment strategies.

[1]  Y. Mizuno,et al.  Quantification of circulating varicella zoster virus-DNA for the early diagnosis of visceral varicella. , 2003, The Journal of infection.

[2]  J. Segovia,et al.  Parvovirus Infection Suppresses Long-Term Repopulating Hematopoietic Stem Cells , 2003, Journal of Virology.

[3]  F. Watzinger,et al.  Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. , 2003, Blood.

[4]  L. To,et al.  An outbreak of respiratory syncytial virus infection in a bone marrow transplant unit: effect on engraftment and outcome of pneumonia without specific antiviral treatment , 2003, Bone Marrow Transplantation.

[5]  C. Rouzioux,et al.  Monitoring Cytomegalovirus Infection in Adult and Pediatric Bone Marrow Transplant Recipients by a Real-Time PCR Assay Performed with Blood Plasma , 2003, Journal of Clinical Microbiology.

[6]  M. Malim,et al.  A Sensitive, Quantitative Assay for Human Immunodeficiency Virus Type 1 Integration , 2002, Journal of Virology.

[7]  K. Yamanishi,et al.  High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. , 2002, Blood.

[8]  M. Schilham,et al.  High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  Raman Kumar,et al.  Evaluation of PCR-based methods for the quantitation of integrated HIV-1 DNA. , 2002, Journal of virological methods.

[10]  B. van der Holt,et al.  Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation. , 2002, Blood.

[11]  P. Reusser Challenges and options in the management of viral infections after stem cell transplantation , 2002, Supportive Care in Cancer.

[12]  E. Claas,et al.  Epstein-Barr virus (EBV)-DNA quantification in pediatric allogenic stem cell recipients: prediction of EBV-associated lymphoproliferative disease. , 2002, Blood.

[13]  K. Roemer,et al.  Evaluation of Use of Epstein-Barr Viral Load in Patients after Allogeneic Stem Cell Transplantation To Diagnose and Monitor Posttransplant Lymphoproliferative Disease , 2002, Journal of Clinical Microbiology.

[14]  P. Bucsky,et al.  PATIENTS AT RISK FOR DEVELOPMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER: PLASMA VERSUS PERIPHERAL BLOOD MONONUCLEAR CELLS AS MATERIAL FOR QUANTIFICATION OF EPSTEIN-BARR VIRAL LOAD BY USING REAL-TIME QUANTITATIVE POLYMERASE CHAIN REACTION1,2 , 2001, Transplantation.

[15]  B. van der Holt,et al.  Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT. , 2001, Blood.

[16]  G. Dini,et al.  Infections after stem cell transplantation in children: state of the art and recommendations , 2001, Bone Marrow Transplantation.

[17]  T. Lion Current recommendations for positive controls in RT-PCR assays , 2001, Leukemia.

[18]  H. Niesters,et al.  Clinical utility of viral quantification as a tool fordisease monitoring , 2001, Expert review of molecular diagnostics.

[19]  C. Boucher,et al.  Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein–Barr virus‐associated lymphoproliferative disease after allogeneic stem cell transplantation , 2001, British journal of haematology.

[20]  Qin Chen,et al.  Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  A. Limaye,et al.  Cytomegalovirus (CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hematopoietic stem-cell transplant recipients. , 2001, The Journal of infectious diseases.

[22]  R. D. de Man,et al.  Development of a Quantitative Real-Time Detection Assay for Hepatitis B Virus DNA and Comparison with Two Commercial Assays , 2000, Journal of Clinical Microbiology.

[23]  C. Sabin,et al.  Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation , 2000, The Lancet.

[24]  I. Ernberg,et al.  Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells. , 2000, Blood.

[25]  M. Eibl,et al.  ENTEROVIRAL MENINGOENCEPHALITIS IN IMMUNOCOMPROMISED CHILDREN AFTER MATCHED UNRELATED DONOR-BONE MARROW TRANSPLANTATION , 2000, Pediatric hematology and oncology.

[26]  P. Griffiths,et al.  The Dynamics of Human Cytomegalovirus Replication in Vivo , 1999, The Journal of experimental medicine.

[27]  R. Hodinka The clinical utility of viral quantitation using molecular methods. , 1998, Clinical and diagnostic virology.

[28]  S. Larsson,et al.  Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time , 1998, Transfusion.

[29]  C. Alfieri,et al.  Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. , 1994, Blood.

[30]  S. Schuval,et al.  Virologic testing in the management of perinatal HIV exposure. , 2003, The AIDS reader.

[31]  M. Buisson,et al.  A prospective study of Epstein–Barr virus load in 85 hematopoietic stem cell transplants , 2002, Bone Marrow Transplantation.

[32]  D. Jungkind Automation of laboratory testing for infectious diseases using the polymerase chain reaction-- our past, our present, our future. , 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[33]  C. Alfieri,et al.  Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease , 1994 .